China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

Core Viewpoint - China Pharma Holdings Inc. will implement a 1-for-5 reverse stock split effective March 6, 2024, with trading to begin on a split-adjusted basis on that day [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will convert every 5 shares of the Company's common stock into 1 share, with no fractional shares issued; any resulting fractional shares will be rounded up to the next whole number [2]. - The reverse stock split was approved by the Company's Board of Directors on October 16, 2023, and adopted by stockholders during the Annual Meeting held on December 17, 2023 [1]. Group 2: Company Overview - China Pharma Holdings, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and marketing products for high-incidence and high-mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases [3]. - The Company operates a cost-effective business model driven by market demand and has a nationwide distribution network across major cities and provinces in China [3]. - The Company's subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province [3].